Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Large Bolus vs Daily Cholecalciferol for Vitamin D Deficiency
NCT04120064Phase 1Terminated
- Sponsor
- Parkview Medical Center
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Parkview Medical Center. Primary endpoint: Efficacy of treatment of vitamin D deficiency: normalization of vitamin D levels above 30ng/mL at 12 months. Started Jan 2019; status: terminated.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT04120064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04120064.